Upvote
Downvote
Associate Director, Translational Toxicology, Preclinical Development
Share Job
- Suggest Revision
Full-time
- We aspire to develop medicines across multiple therapeutic modalities, including RNA editing, splicing and silencing, using our proprietary discovery and drug development platform that combines best-in-class nucleic acid chemistry with the ability to target disease biology in new ways.
- In 2023 we are executing against multiple milestones, including advancing our differentiated exon skipping portfolio in Duchenne muscular dystrophy, bringing the first-ever investigational RNA editing therapeutic into clinical development, and announcing our next slate of pipeline programs.
- The candidate should possess an in-depth understanding of safety pharmacology, investigative and regulatory toxicology, and have experience designing and critically evaluating results of exploratory and GLP-compliant toxicology studies.
- DVM/PhD or PhD in biology, toxicology or related field, Board certification in toxicology is highly desirable
- Represent PCDS at team meetings and coordinate between PCDS and other functions including CMC, Regulatory Affairs, Clinical Operations, and Platform and Discovery Sciences
Active Job
Updated TodaySimilar Job
Relevance
Active